Rosemary Gibson

Rosemary Gibson is a senior advisor at The Hastings Center and an author known for her work on healthcare, patient safety, and pharmaceutical supply chain issues. Her research and writing have focused particularly on the U.S. healthcare system's vulnerabilities and dependencies on foreign drug manufacturing. Gibson gained prominence with her 2018 book "China Rx: Exposing the Risks of America's Dependence on China for Medicine," which examined the pharmaceutical supply chain and national security implications of drug manufacturing outsourcing. She has authored several other influential books including "Wall of Silence," "The Treatment Trap," and "Medicare Meltdown." Her work has influenced healthcare policy discussions at the national level, including testimony before Congress on pharmaceutical supply chain security and healthcare safety issues. Gibson previously held positions at the Robert Wood Johnson Foundation and has served on various national healthcare quality and safety initiatives. Gibson's writing and research continue to focus on critical issues in healthcare delivery, medical errors, and the intersection of healthcare policy with national security concerns. She regularly contributes to policy discussions through articles, speaking engagements, and media appearances.

Readers value Gibson's investigative approach and research into healthcare and pharmaceutical supply chains. Her books received high marks for exposing systemic problems and backing claims with data. Readers appreciated: - Clear explanations of complex healthcare issues - Documentation of safety risks in medical systems - Specific examples and case studies - Solutions-focused recommendations Common criticisms: - Writing can be repetitive - Some sections read like technical reports - Limited coverage of successful healthcare models - Focus on problems over solutions Ratings across platforms: Amazon: 4.5/5 average across books (2,100+ reviews) Goodreads: 4.2/5 average (1,800+ reviews) "China Rx" and "Wall of Silence" received the most reader engagement. Multiple readers called the books "eye-opening" regarding drug supply vulnerabilities. Healthcare professionals commented that the books validated their experiences. Some readers found the level of detail overwhelming, with one noting it "reads more like a research paper than a book for general audiences."

The Treatment Trap (2010) Examines the problem of overtreatment in American healthcare, documenting how financial incentives and medical culture can lead to unnecessary procedures and tests.

Wall of Silence (2003) Investigates medical errors in the U.S. healthcare system and their impact on patients, documenting real cases and systemic issues in patient safety.

Medicare Meltdown (2013) Analyzes challenges facing Medicare and its future sustainability, exploring financial pressures and systemic problems within the program.

China Rx (2018) Details America's dependence on Chinese pharmaceutical manufacturing and examines the potential risks to drug supply chains and national security.

Battle Over Health Care (2012) Chronicles the debate over healthcare reform in America, examining key issues and competing interests in the healthcare system.

Katherine Eban investigates pharmaceutical manufacturing and supply chain issues, with a focus on drug quality and safety concerns in global production. Her book "Bottle of Lies" explores FDA oversight of overseas drug manufacturing and the challenges of ensuring medication safety.

Marcia Angell examines the pharmaceutical industry's influence on medical practice and healthcare policy through her work as former editor-in-chief of the New England Journal of Medicine. Her book "The Truth About the Drug Companies" analyzes how pharmaceutical companies operate and influence healthcare decisions.

Charles Ornstein reports on healthcare system failures, medical errors, and corporate influence in medicine through investigative journalism. His work with ProPublica has exposed systemic issues in healthcare delivery and patient safety.

Elisabeth Rosenthal investigates healthcare costs and systemic problems in the U.S. medical system based on her experience as both a physician and journalist. Her book "An American Sickness" examines the financial structures that drive healthcare decisions and costs.

Robert Pearl writes about healthcare reform and system transformation based on his experience as CEO of The Permanente Medical Group. His books analyze why healthcare systems fail and how to implement effective changes in medical delivery.